Celeste P. Durnwald, M.D.
Associate Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania
Attending, Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia, PA
Attending, Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA
Director, High Risk OB Clinic, Dickens Center for Women’s Health, Hospital of the University of Pennsylvania, Philadelphia, PA
Director, Perinatal Diabetes Program, Hospital of the University of Pennsylvania, Philadelphia, PA
Attending, Gynecology & Neonatology, Penn Presbyterian Medical Center, Philadelphia, PA
Director, Maternal Fetal Medicine Fellowship, University of Pennsylvania
Department: Obstetrics and Gynecology
Contact information
Hospital of the University of Pennsylvania
Obstetrics and Gynecology
Division of Maternal Fetal Medicine
3400 Spruce Street, 2000 Courtyard
Philadelphia, PA 19104
Obstetrics and Gynecology
Division of Maternal Fetal Medicine
3400 Spruce Street, 2000 Courtyard
Philadelphia, PA 19104
Education:
BS (Integrated Life Sciences)
Kent State University, 1993.
MD
Northeastern Ohio Universities, 1997.
Permanent linkBS (Integrated Life Sciences)
Kent State University, 1993.
MD
Northeastern Ohio Universities, 1997.
Description of Research Expertise
Areas of research interest include: 1) diabetes in pregnancy, 2) obesity,3) maternal metabolism
Selected Publications
Scott K, Ledyard RF, Darden N, Durnwald C, Handley SC, Nelin TD, Power M, Sinclair TR, Burris HH.: Postpartum care receipt among parents of preterm infants admitted to the neonatal intensive care unit. Am J Obstet Gynecol MFM. 7(5), May 2025.Tienhoven XAV, Zafman K, Bender WR, Durnwald C.: Hemoglobin A1c among patients without diabetes and risk of large for gestational age neonates. Am J Obstet Gynecol MFM. May 2025.
Szmuilowicz ED, Durnwald C, Feig DS.: Practical Approach to Continuous Glucose Monitoring (CGM) Interpretation and Automated Insulin Delivery (AID) Use in Pregnancy: Considerations for Obstetric Providers. J Diabetes Sci Technol. May 2025.
Burris HH, Darden N, Power M, Walker L, Ledyard R, Reiter J, Lewey J, Trout KK, Tan M, Gregory EF, DeMauro SB, Lorch SA, Christ L, Handley SC, Montoya-Williams D, Durnwald C.: Postpartum Care in the Neonatal intensive Care Unit (PeliCaN) - a Randomized Controlled Trial. Am J Obstet Gynecol MFM. May 2025.
Carlson AL, Beck RW, Li Z, Norton E, Bergenstal RM, Johnson M, Dunnigan S, Banfield M, Krumwiede K, Sibayan J, Calhoun P, Durnwald C.: Continuous Glucose Monitoring-Measured Glucose Levels During Oral Glucose Tolerance Testing in Pregnancy. Diabetes Technol Ther. Apr 2025.
Prior AK, Dolin CD, Bender W, Durnwald CP, Hamm RF.: Utilization of a Postpartum Fasting Blood Glucose to Predict Impaired Glucose Tolerance in Patients with Gestational Diabetes Mellitus. Am J Perinatol. 42(6), Apr 2025.
Richterman A, Aitcheson N, Durnwald C, Curley C, Short WR, Louis MJ, Momplaisir F, Thirumurthy H: Mental Bandwidth is Associated with HIV and Viral Suppression Among Low-Income Women in Philadelphia. AIDS Behav. 29(2):556-561, Feb 2025.
Sarker M, Jacobs MB, Boggess K, Battarbee AN, Refuerzo J, Zork N, Eichelberger K, Durnwald C, Landon M, Aagaard K, Wallace K, Scifres C, Longo S, Stuebe A, Ramos GA.: Breastfeeding patterns among parturients with diabetes: a secondary analysis of the MOMPOD randomized clinical trial. Pregnancy (Hoboken). 1(1), Jan 2025.
Prior AK, Dolin C, Bender WR, Durnwald C, Hamm RF: Effects of implementing a routine postpartum fasting blood glucose on the completion of the gold standard 2-hour oral glucose tolerance test in gestational diabetics. Am J Perinatol. 41(16):2284-2289, Dec 2024.
Patel M, Battarbee AN, Refuerzo JS, Zork N, Eichelberger K, Ramos GA, Olson G, Durnwald C, Landon MB, Aagaard KM, Wallace K, Scifres C, Rosen T, Mulla W, Valent A, Longo S, Boggess KA: Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia. Obstet Gynecol 144(5):733-739, Nov 2024.